GE HealthCare has announced its latest LOGIQ ultrasound systems, promising to speed up diagnosis and reduce the complexity of daily clinical practice. The new portfolio includes the LOGIQ E10 Series, LOGIQ Fortis, and LOGIQ Totus, all equipped with what the company calls Verisound Digital and AI innovations.
The timing matters. Healthcare providers face rising imaging volumes while dealing with tighter time and resource constraints. The company says these systems are designed to help clinicians get from image to diagnosis faster, especially in high-pressure environments.
How does it work?
The new LOGIQ systems combine several key technologies. At the core is an enhanced imaging platform with expanded transducer options, including specialty probes and the wireless Vscan Air device.
The AI component centers on what GE calls Auto Abdominal Suite 2.0. This tool automatically detects and segments anatomy, improves measurement accuracy, and reduces the number of manual system interactions needed. The suite includes automated color assistance, aorta measurements, and bile duct assessments.
A standout feature is Ultrasound-Guided Fat Fraction (UGFF), which assesses liver fat content. This tool aims to provide more consistent evaluation of fatty liver disease, helping doctors monitor disease progression and determine treatment timing.
The systems also feature an expanded digital platform that integrates third-party applications alongside GE’s own tools. This includes on-scanner reporting capabilities through ViewPoint technology.
Why does it matter?
Liver disease represents a massive global health challenge. Nearly 40% of the world’s population has fatty liver disease, but most cases go undiagnosed and untreated. The condition has become significantly more common over the past three decades.
Early detection makes a difference. Ultrasound serves as a first-line tool for spotting liver changes because it’s widely available and familiar to clinicians. The enhanced liver assessment capabilities could help catch more cases earlier.
The workflow improvements also address real pain points. GE’s internal testing showed the AI tools supported 65% faster measurements and 80% fewer system interactions. In busy clinical environments, those efficiency gains add up quickly.
The broader trend matters too. As medical imaging volumes continue climbing, healthcare systems need tools that can maintain quality while moving faster. These systems represent one approach to that challenge.
The context
GE HealthCare has been developing LOGIQ ultrasound systems for over 30 years. The company spun off from General Electric in 2023 and now operates as an independent $19.6 billion medical technology business with 51,000 employees worldwide.
The new systems will debut at the European Congress of Radiology in Vienna from March 4-7, 2026. They’ve received 510(k) clearance from the FDA and CE marking for European markets, with availability in other regions where regulatory approval has been granted.
This launch comes as the ultrasound market faces increasing competition, with companies racing to integrate AI capabilities and improve workflow efficiency. GE’s approach focuses on full-body imaging applications rather than specialized niches, positioning the systems as versatile tools for general practice.
The liver disease focus reflects broader healthcare trends. As metabolic disorders become more common globally, medical device companies are developing tools specifically for earlier detection and monitoring of related conditions.